STOCK TITAN

Spruce Biosciences, Inc. (SPRB) Net Income by Year

SPRB

Spruce Biosciences, Inc. reported a net loss of $39.0M in fiscal year 2025. This represents an increase of 26.5% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Spruce Biosciences, Inc. has filed alongside them.

FY2025 annual
Net Income -$39.0M
YoY +26.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SPRB Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$39.0M+26.5%-$53.0M-10.7%-$47.9M-3.8%-$46.2M-9.2%-$42.3M-43.2%-$29.5M-125.7%-$13.1M

SPRB Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$16.2M-685.1%-$12.3M+12.6%N/A-$8.2M+5.3%-$2.1M+77.5%-$14.0M-20.8%-$23.6M-136.8%-$8.7M+29.8%-$9.2M+28.4%-$11.6M+9.1%-$9.9M-$12.4M-8.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Spruce Biosciences, Inc. financials

Frequently Asked Questions

What was Spruce Biosciences, Inc.'s net income in fiscal year 2025?

Spruce Biosciences, Inc. reported a net loss of $39.0M in fiscal year 2025.

How fast is Spruce Biosciences, Inc.'s net income growing?

Spruce Biosciences, Inc. (SPRB) net income rose by 26.5% year over year, from -$53.0M to -$39.0M in fiscal year 2025.

How has Spruce Biosciences, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, Spruce Biosciences, Inc. (SPRB) net income went from -$13.1M in fiscal year 2019 to -$39.0M in fiscal year 2025.

Spruce Biosciences, Inc. (SPRB) reported -$16.2M in net income in Q2 2026. This represents a decrease of 685.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Spruce Biosciences, Inc. (SPRB) reported on that line in every period on record.